Conditional survival for longer-term survivors from 2000–2004 using population-based cancer registry data in Osaka, Japan

BMC Cancer

Yuri Ito¹  Tomio Nakayama¹  Isao Miyashiro¹  Akiko Ioka¹  Hideaki Tsukuma¹ 

[1] Center for Cancer Control and Statistics, Osaka Medical Center for Cancer and Cardiovascular Diseases, 3-3 Nakamichi 1-Chome, Higashinari-ku, Osaka 537-8511, Japan

关键词: Japan;    Relative survival;    Cancer registries;    Conditional survival;   

Others  :  1079686
DOI  :  10.1186/1471-2407-13-304

 received in 2013-03-19, accepted in 2013-06-14,  发布年份 2013

【 摘 要 】

Background

We usually report five-year survival from population-based cancer registries in Japan; however these survival estimates may be pessimistic for cancer survivors, because many patients with unfavourable prognosis die shortly after diagnosis. Conditional survival can provide relevant information for cancer survivors, their family and oncologists.

Methods

We used the period approach to estimate the latest 10-year survival of 38,439 patients with stomach, colorectal, lung, breast and prostate cancer diagnosed between 1990 and 2004 and followed-up from 2000–04 in Osaka, Japan. Conditional survival is an estimate, with the pre-condition of having already survived a certain length of time. Conditional five-year relative survival of one to five years after diagnosis was calculated by site, age and stage for survivors under the age of 70.

Results

Five-year relative survival for stomach cancer was 60%. Conditional five-year relative survival was 77% one year after diagnosis and 97% five years after diagnosis. This means that 97% of patients who survive five years after diagnosis can survive a further five years. Conditional five-year relative survival improved successively with each additional year that patients lived after diagnosis for stomach, colorectal and lung cancer. These figures for breast and prostate cancer were stable at high survival. Liver cancer did not show an increase in conditional five-year survival.

Conclusion

Conditional five-year survival is a relevant figure for long-term cancer survivors in Japan. It is important for population-based cancer registries to provide figures which cancer patients and oncologists really need.

【 授权许可】

   
2013 Ito et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]National Research Council: 2 Cancer Survivors. In From Cancer Patient to Cancer Survivor: Lost in Transition. Edited by Hewitt M, Greenfield S, Stovall E. Washington D.C.: The National Academies Press; 2005:23-65.
• [2]Yu XQ, Baade PD, O’Connell DL: Conditional survival of cancer patients: an Australian perspective. BMC Cancer 2012, 12:460. BioMed Central Full Text
• [3]Allemani C, Minicozzi P, Berrino F, Bastiaannet E, Gavin A, Galceran J, Ameijide A, Siesling S, Mangone L, Ardanaz E, et al.: Predictions of survival up to 10 years after diagnosis for European women with breast cancer in 2000–2002. Int J Cancer 2013, 132(10):2404-2412.
• [4]Abbott AM, Habermann EB, Parsons HM, Tuttle T, Al-Refaie W: Prognosis for primary retroperitoneal sarcoma survivors: a conditional survival analysis. Cancer 2012, 118(13):3321-3329.
• [5]Ellison LF, Bryant H, Lockwood G, Shack L: Conditional survival analyses across cancer sites. Health Rep 2011, 22(2):21-25.
• [6]Baade PD, Youlden DR, Chambers SK: When do I know I am cured? Using conditional estimates to provide better information about cancer survival prospects. Med J Aust 2011, 194(2):73-77.
• [7]Xing Y, Chang GJ, Hu CY, Askew RL, Ross MI, Gershenwald JE, Lee JE, Mansfield PF, Lucci A, Cormier JN: Conditional survival estimates improve over time for patients with advanced melanoma: results from a population-based analysis. Cancer 2010, 116(9):2234-2241.
• [8]Merrill RM, Hunter BD: Conditional survival among cancer patients in the United States. Oncologist 2010, 15(8):873-882.
• [9]Janssen-Heijnen ML, Houterman S, Lemmens VE, Brenner H, Steyerberg EW, Coebergh JW: Prognosis for long-term survivors of cancer. Ann Oncol 2007, 18(8):1408-1413.
• [10]Skuladottir H, Olsen JH: Conditional survival of patients with the four major histologic subgroups of lung cancer in Denmark. J Clin Oncol 2003, 21(16):3035-3040.
• [11]Bryant H, Lockwood G, Rahal R, Ellison L: Conditional survival in Canada: adjusting patient prognosis over time. Current oncol (Toronto Ont) 2012, 19(4):222-224.
• [12]The Basic Plan to Promote Cancer Control Programmes in Japan. http://www.mhlw.go.jp/shingi/2007/06/dl/s0615-1a.pdf webcite [in Japanese]
• [13]World Health Organization: International Classification of Diseases, 10th revision.
• [14]Berkson J, Gage R: Calculation of survival rates for cancer. Proceed Staff Meeting Mayo Clinic 1950, 25:270-286.
• [15]Esteve J, Benhamou E, Croasdale M, Raymond L: Relative survival and the estimation of net survival: elements for further discussion. Stat Med 1990, 9(5):529-538.
• [16]Cancer Research UK Cancer Survival Group, London School of Hygiene and Tropical Medicine: strel computer program version 1.2.7 for cancer survival analysis. 2009.
• [17]Abridged life tables in Japan for 1962–2011. http://ganjoho.jp/professional/statistics/cohort01.html webcite [in Japanese]
• [18]Brenner H, Gefeller O: Deriving more up-to-date estimates of long-term patient survival. J Clin Epidemiol 1997, 50(2):211-216.
• [19]Rubin DB: Multiple Imputation for Nonresponse in Surveys. New York: John Wiley & Sons; 1987.
• [20]StataCorp: Stata Statistical Software: Release 12. College Station. TX: StataCorp LP; 2011.
• [21]Verdecchia A, De Angelis R, Capocaccia R, Sant M, Micheli A, Gatta G, Berrino F: The cure for colon cancer: results from the EUROCARE study. Int J Cancer 1998, 77(3):322-329.
• [22]Lambert PC, Thompson JR, Weston CL, Dickman PW: Estimating and modeling the cure fraction in population-based cancer survival analysis. Biostatistics 2007, 8(3):576-594.
• [23]Isobe Y, Nashimoto A, Akazawa K, Oda I, Hayashi K, Miyashiro I, Katai H, Tsujitani S, Kodera Y, Seto Y, et al.: Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry. Gastric cancer official j Int Gastric Cancer Association Japanese Gastric Cancer Association 2011, 14(4):301-316.
• [24]Hamashima C, Shibuya D, Yamazaki H, Inoue K, Fukao A, Saito H, Sobue T: The Japanese guidelines for gastric cancer screening. Jpn J Clin Oncol 2008, 38(4):259-267.
• [25]Toyoda Y, Nakayama T, Ioka A, Tsukuma H: Trends in lung cancer incidence by histological type in Osaka. Japan Jpn J Clin Oncol 2008, 38(8):534-539.
• [26]Devesa SS, Bray F, Vizcaino AP, Parkin DM: International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer 2005, 117(2):294-299.
• [27]de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, Plummer M: Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 2012, 13(6):607-615.